Manulife (Manufacturers Life Insurance)
VIRX

Manulife (Manufacturers Life Insurance)’s Viracta Therapeutics, Inc. Common Stock VIRX Stock Holding History

Manulife (Manufacturers Life Insurance)’s Portfolio VIRX Stock Details VIRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q2 		– Sell
-10,243
Closed -$48.8K – 3168
2022
Q1 		$48.8K Sell
10,243
-6,564
-39% -$19.8K ﹤0.01% 3042
2021
Q4 		$61 Sell
16,807
-4,571
-21% -$24.4K ﹤0.01% 3083
2021
Q3 		$171K Sell
21,378
-497
-2% -$4.9K ﹤0.01% 3033
2021
Q2 		$248K Buy
+21,875
New +$219K ﹤0.01% 2955
2018
Q3 		– Sell
-43
Closed -$3K – 3934
2018
Q2 		$3K Hold
43
– – ﹤0.01% 4174
2018
Q1 		$4K Buy
+43
New +$7.37K ﹤0.01% 4167
2017
Q3 		– Sell
-8
Closed -$1K – 4357
2017
Q2 		$1K Sell
8
-1
-11% -$115 ﹤0.01% 4276
2017
Q1 		$1K Hold
9
– – ﹤0.01% 4100
2016
Q4 		$1K Hold
9
– – ﹤0.01% 4248
2016
Q3 		$1K Hold
9
– – ﹤0.01% 4197
2016
Q2 		$1K Hold
9
– – ﹤0.01% 4155
2016
Q1 		$1K Hold
9
– – ﹤0.01% 4038
2015
Q4 		$2 Hold
9
– – ﹤0.01% 3826
2015
Q3 		$2 Hold
9
– – ﹤0.01% 3857
2015
Q2 		$6 Sell
9
-168
-95% -$89.3K ﹤0.01% 3666
2015
Q1 		$91 Buy
177
+81
+84% +$40.9K ﹤0.01% 3200
2014
Q4 		$52 Sell
96
-59
-38% -$26.6K ﹤0.01% 3226
2014
Q3 		$232 Sell
155
-5
-3% -$7.24K ﹤0.01% 2541
2014
Q2 		$219K Buy
160
+29
+22% +$33.6K ﹤0.01% 2654
2014
Q1 		$182 Buy
131
+4
+3% +$4.65K ﹤0.01% 2791
2013
Q4 		$126 Sell
127
-4
-3% -$4.14K ﹤0.01% 2978
2013
Q3 		$137 Sell
131
-5
-4% -$5.34K ﹤0.01% 2920
2013
Q2 		$149K Buy
+136
New +$152K ﹤0.01% 2788

Other funds holding VIRX

BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
LCM
Laurion Capital Management New York $2.29B AUM 75.73% 1-Year Est. Return
SB
Samsara BioCapital Palo Alto, California $1.03B AUM 214.94% 1-Year Est. Return
MCM
MAI Capital Management Independence, Ohio $17.7B AUM 18.87% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
ACM
Aisling Capital Management New York $476M AUM 128.63% 1-Year Est. Return

Manulife (Manufacturers Life Insurance)'s VIRX Position: Q2 2022 in Review

Manulife (Manufacturers Life Insurance) sold out of Viracta Therapeutics, Inc. Common Stock (VIRX) in Q2 2022, closing a stake of 10,243 shares — an estimated $48.8K sold.

Manulife (Manufacturers Life Insurance) first reported a position in VIRX in Q2 2013 and held it in 23 quarters. The position peaked at $248K in Q2 2021. 63 funds tracked by Wall St. Rank hold VIRX as of Q2 2022.

  • Manulife (Manufacturers Life Insurance) reported no remaining Viracta Therapeutics, Inc. Common Stock position as of Q2 2022 after selling out during the quarter.
  • Manulife (Manufacturers Life Insurance) sold 10,243 Viracta Therapeutics, Inc. Common Stock shares in Q2 2022, an estimated $48.8K.
  • Manulife (Manufacturers Life Insurance) first reported a position in Viracta Therapeutics, Inc. Common Stock in Q2 2013 and held it in 23 quarters.
  • Manulife (Manufacturers Life Insurance)'s Viracta Therapeutics, Inc. Common Stock position peaked at $248K in Q2 2021.
  • 63 funds tracked by Wall St. Rank held Viracta Therapeutics, Inc. Common Stock as of Q2 2022.

Based on Manulife (Manufacturers Life Insurance)'s 13F filing for Q2 2022, filed 15 Aug 2022.